Croda International Plc (LON:CRDA)

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Europe, Middle East & Africa Revenue	685.10M	626.50M
Europe, Middle East & Africa Revenue Growth	9.35%	-9.23%
North America Revenue	401.10M	393.00M
North America Revenue Growth	2.06%	-0.91%
Latin America Revenue	186.70M	180.50M
Latin America Revenue Growth	3.44%	-2.64%
Asia Revenue	426.50M	428.10M
Asia Revenue Growth	-0.37%	1.37%
Revenue (Total)	1.70B	1.63B
Revenue (Total) Growth	4.38%	-3.92%

Revenue

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Consumer Care Revenue	972.70M	920.00M
Consumer Care Revenue Growth	5.73%	3.83%
Life Science Revenue	532.20M	504.30M
Life Science Revenue Growth	5.53%	-16.27%
Industrial Specialties Revenue	194.50M	203.80M
Industrial Specialties Revenue Growth	-4.56%	-1.12%
Revenue (Total)	1.70B	1.63B
Revenue (Total) Growth	4.38%	-3.92%

Adjusted EBIT

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Consumer Care Adjusted Operating Profit	169.80M	160.20M
Consumer Care Adjusted Operating Profit Growth	5.99%	-0.06%
Life Science Adjusted Operating Profit	116.50M	104.00M
Life Science Adjusted Operating Profit Growth	12.02%	-30.80%
Industrial Specialties Adjusted Operating Profit	9.00M	15.50M
Industrial Specialties Adjusted Operating Profit Growth	-41.94%	64.89%
Operating Income (Total)	110.10M	227.50M
Operating Income (Total) Growth	-51.60%	-8.08%

Key Performance Indicators

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Sales Growth due to Price/Mix	-3.00%	-5.50%
Sales Growth due to Volume	9.60%	6.90%

Data Source: Fiscal.ai Last updated: Feb 24, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 12, 2026

Data Sources Report a data error